331 related articles for article (PubMed ID: 27208498)
1. Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials.
McIntyre RS; Weiller E; Zhang P; Weiss C
J Affect Disord; 2016 Sep; 201():116-23. PubMed ID: 27208498
[TBL] [Abstract][Full Text] [Related]
2. Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress: Post Hoc Analysis of Three Placebo-Controlled Studies.
McIntyre RS; Bubolic S; Zhang Z; MacKenzie EM; Therrien F; Miguelez M; Boucher M
J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):133-140. PubMed ID: 38421922
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder.
Hobart M; Skuban A; Zhang P; Augustine C; Brewer C; Hefting N; Sanchez R; McQuade RD
J Clin Psychiatry; 2018 May; 79(4):. PubMed ID: 29873953
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies.
Nelson JC; Weiller E; Zhang P; Weiss C; Hobart M
J Affect Disord; 2018 Feb; 227():103-108. PubMed ID: 29055257
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study.
Hobart M; Skuban A; Zhang P; Josiassen MK; Hefting N; Augustine C; Brewer C; Sanchez R; McQuade RD
Curr Med Res Opin; 2018 Apr; 34(4):633-642. PubMed ID: 29343128
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study.
Thase ME; Youakim JM; Skuban A; Hobart M; Zhang P; McQuade RD; Nyilas M; Carson WH; Sanchez R; Eriksson H
J Clin Psychiatry; 2015 Sep; 76(9):1232-40. PubMed ID: 26301771
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants.
Thase ME; Youakim JM; Skuban A; Hobart M; Augustine C; Zhang P; McQuade RD; Carson WH; Nyilas M; Sanchez R; Eriksson H
J Clin Psychiatry; 2015 Sep; 76(9):1224-31. PubMed ID: 26301701
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study.
Davis LL; Ota A; Perry P; Tsuneyoshi K; Weiller E; Baker RA
Brain Behav; 2016 Oct; 6(10):e00520. PubMed ID: 27781135
[TBL] [Abstract][Full Text] [Related]
9. Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment.
Weisler RH; Ota A; Tsuneyoshi K; Perry P; Weiller E; Baker RA; Sheehan DV
J Affect Disord; 2016 Nov; 204():40-7. PubMed ID: 27322768
[TBL] [Abstract][Full Text] [Related]
10. A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder.
Bauer M; Hefting N; Lindsten A; Josiassen MK; Hobart M
Acta Neuropsychiatr; 2019 Feb; 31(1):27-35. PubMed ID: 30223911
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies.
Thase ME; Zhang P; Weiss C; Meehan SR; Hobart M
Expert Opin Pharmacother; 2019 Oct; 20(15):1907-1916. PubMed ID: 31290344
[No Abstract] [Full Text] [Related]
12. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies.
Thase ME; Weiller E; Zhang P; Weiss C; McIntyre RS
Neuropsychiatr Dis Treat; 2019; 15():37-45. PubMed ID: 30587996
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive brexpiprazole 1 mg and 2 mg daily for Japanese patients with major depressive disorder following inadequate response to antidepressants: a phase 2/3, randomized, double-blind (BLESS) study.
Kato M; Shiosakai M; Kuwahara K; Iba K; Shimada Y; Saito M; Isogai Y; Sekine D; Aoki K; Koga N; Higuchi T
Psychiatry Clin Neurosci; 2024 Feb; 78(2):113-122. PubMed ID: 37933521
[TBL] [Abstract][Full Text] [Related]
15. Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: a pooled analysis.
Stewart TD; Hatch A; Largay K; Sheehan JJ; Marler SV; Berman RM; Nelson JC
J Affect Disord; 2014 Jun; 162():20-5. PubMed ID: 24766999
[TBL] [Abstract][Full Text] [Related]
16. Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study.
Krystal AD; Mittoux A; Meisels P; Baker RA
Prim Care Companion CNS Disord; 2016 Sep; 18(5):. PubMed ID: 27835722
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.
Berman RM; Marcus RN; Swanink R; McQuade RD; Carson WH; Corey-Lisle PK; Khan A
J Clin Psychiatry; 2007 Jun; 68(6):843-53. PubMed ID: 17592907
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder.
Sussman M; Yu J; Kamat SA; Hartry A; Legacy S; Duffy R; Aigbogun MS
J Affect Disord; 2017 Jan; 207():54-62. PubMed ID: 27693466
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive Brexpiprazole: A Review in Major Depressive Disorder.
McKeage K
CNS Drugs; 2016 Feb; 30(2):91-9. PubMed ID: 26849053
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale.
Hobart M; Zhang P; Weiss C; Meehan SR; Eriksson H
Int J Neuropsychopharmacol; 2019 Mar; 22(3):173-179. PubMed ID: 30508090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
